Clinical [qlco]
Efficacy [qlco]
Raloxifene [orch, phsu]
postmenopausal [tmco]
Women [popg]
New [tmco]
Class [inpr]
Compound [qlco]
Known [qlco]
Selective Estrogen Receptor Modulators [horm, phsu]
possess [mobd]
Optimal [qlco]
Combination [qlco]
Characteristics [qlco]
Drug [phsu]
Design [acty]
postmenopausal [tmco]
Women [popg]
Class [inpr]
Compound [qlco]
Raloxifene [orch, phsu]
Most [qnco]
Study [mnob]
Currently [tmco]
Available [ftcn]
Clinical [qlco]
Countries [geoa]
Prevention [topp]
Osteoporosis [dsyn]
Post-Menopause [orgf]
Women [popg]
Raloxifene [orch, phsu]
Non [ftcn]
Steroid [strd]
Derivative [ftcn]
Show [inpr]
To [qlco]
PREVENT [phsu]
Bone Loss [patf]
Axial [spco]
Sites [spco]
serum cholesterol [lbpr]
Estrogen [horm, phsu, strd]
rats [mamm]
postmenopausal [tmco]
Women [popg]
Models, Animal [anim]
Estrogen [horm, phsu, strd]
Raloxifene [orch, phsu]
Not [ftcn]
Breast [bpoc]
Uterine [bpoc]
Tissues [tisu]
appealing [gora]
Attribute [idcn]
Make [ftcn]
Raloxifene [orch, phsu]
Potential [qlco]
treatment [ftcn]
Osteoporosis [dsyn]
Menopause [phsf]
Risks [qlco]
Middle Aged [aggp]
Elderly woman [aggp]
Multicenter Studies [resa]
Performed [ftcn]
Early [tmco]
postmenopausal [tmco]
Women [popg]
Assigned [ftcn]
To [qlco]
Receive [qlco]
Raloxifene [orch, phsu]
mg day [qnco]
placebo [topp]
Subject [grup]
Received [qlco]
Calcium supplement [food]
Bone Mineral Density [clna]
Measured [qlco]
Twice [inpr]
months [tmco]
Absorptiometry, Dual X-Ray [diap]
Decreased [qnco]
skeletal [bdsy]
Sites [spco]
placebo [topp]
Increased [qnco]
Raloxifene [orch, phsu]
Spine [bpoc]
Hip [bpoc]
Total body [ffas]
Three [qnco]
Doses [qnco]
months [tmco]
Mean [qnco]
Increase [ftcn]
Compared [acty]
placebo [topp]
Lumbar spine [bpoc]
Hip [bpoc]
Total body [ffas]
Marker [clna]
Bone Formation [ortf]
Serum [bdsu]
Osteocalcin [aapp, bacs]
Bone Specific Alkaline Phosphatase [lbpr]
Resorption [orgf]
urinary [qlco]
CrossLaps [aapp]
TM [aapp, rcpt]
Decreased [qnco]
premenopausal [tmco]
Range [qnco]
treatment [ftcn]
Raloxifene [orch, phsu]
Addition [ftcn]
Serum [bdsu]
Low Density Lipoprotein Cholesterol [bacs, strd]
Decreased [qnco]
Raloxifene [orch, phsu]
therapy [ftcn]
Group [idcn]
Dose [qnco]
Serum HDL Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Not [ftcn]
Changed [ftcn]
therapy [ftcn]
Most [qnco]
Observed [ftcn]
Side Effect [patf]
Hot [qlco]
Patients [podg]
Take [hlca]
Raloxifene [orch, phsu]
Reporting [hlca]
Slightly [idcn]
High [qlco]
Rate [acty]
placebo [topp]
This [euka]
Adverse event [fndg]
Occurred [acty]
First [qnco]
months [tmco]
therapy [ftcn]
Mild [qlco]
Not [ftcn]
Result [ftcn]
Excess [qlco]
Study [mnob]
Dropout [popg]
Raloxifene [orch, phsu]
placebo [topp]
Preliminary [tmco]
Data [idcn]
Indicated [fndg]
Raloxifene [orch, phsu]
Not [ftcn]
Associated [qlco]
Increased [qnco]
Risk [qlco]
Breast Cancer [neop]
summary [inpr]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
Raloxifene [orch, phsu]
Very [qlco]
promise [idcn]
Compound [qlco]
Attractive [qlco]
choice [inbe]
postmenopausal [tmco]
Women [popg]
[c] [qnco]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
